Zimmer Biomet Holdings generated $8.4B in trailing twelve-month revenue, up 0.1% year-over-year. Net income was $761.1M with a 9.05% net margin. Gross margin stands at 70.03% and operating margin at 14.02%. Diluted EPS is $3.86, which declined 0.1% year-over-year. Based on the Q1 2026 filing.